← Evidence map

TrialBlood2025

Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial.

Davide Matino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40608864